| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 1.71 Billion |
| Market Size (2030) | USD 2.68 Billion |
| CAGR (2025 - 2030) | 9.45 % |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
China Minimally Invasive Surgery Devices Market Analysis
The China Minimally Invasive Surgery Devices Market size is estimated at USD 1.71 billion in 2025, and is expected to reach USD 2.68 billion by 2030, at a CAGR of 9.45% during the forecast period (2025-2030).
The COVID-19 pandemic caused a drop in the market in 2020 as the number of elective and planned surgeries had been drastically reduced. Further, the logistical restrictions, disrupted raw material supplies, and hospitals' economic instabilities led to a market decline.
- Factors such as smaller incisions, reduction in healing time, reduced anastatic use, decreased hospital stays, and improved accuracy have improved product adoption of Minimally Invasive Surgery (MIS) devices by most surgeons across the country.
- In recent years, China's rapidly aging population and rising income level have put the spotlight on China's health system. According to South China Morning Post, China's aging crisis is deepening with the falling number of new births. According to the same source, China had 280.04 million people over 60 at the end of the last year, up from 267.36 million people or 18.9 percent of the population at the end of 2021.
- Thus, aging and significant government investment have provided the country's healthcare sector with new growth avenues. For instance, the 2009 Health Reform made by the government increased fiscal subsidies for public health from RMB15 per capita in 2009 to RMB84 per capita in the last year. Therefore, the rising affordability of the general population towards healthcare services is driving the growth of the Minimally Invasive Surgery market in China.
- Increased investments in healthcare infrastructure by various organizations and hospitals are expected to create opportunities for manufacturers. Surgical wards in newly built hospitals are envisioned to be equipped with advanced surgical equipment to provide a high standard of medical care in China, which is expected to propel market growth over the forecast period.
- The increasing prevalence and fatality of chronic diseases in China demand innovative and advanced solutions to counter evolving health problems. According to SpringerLink, last year, approximately 2.79 million cases and 1.94 million deaths occurred in older Chinese people. This presents 55.8% and 68.2% of cases and deaths in all populations in the country.
China Minimally Invasive Surgery Devices Market Trends
The Cardiac Segment is Expected to Hold a Large Market Share Over the Forecast Period
- The clinical demand for treating severe aortic stenosis is expected to increase due to the aging population in China. China not only has the largest population on earth (with more than 1.4 billion people) but is also one of the countries with the fastest aging population.
- This is primarily due to decades of falling birth rates on the one hand and steeply rising life expectancy on the other. According to a survey by the United Nations, the share of the population older than 65 in China in 2035 is estimated to be 20.7% of its total population.
- Because of its large population base, China is facing a growing number of pediatric and adult CHD patients. Moreover, according to China CDC, it has been estimated that nearly 330 million patients suffer from CVD in China. The number of patients suffering from different heart diseases such as coronary heart disease, stroke, heart failure, pulmonary heart disease, atrial fibrillation, rheumatic heart disease, congenital heart disease, lower extremity artery disease, and hypertension is 11.39 million, 13.00 million, 8.90 million, 5.00 million, 4.87 million, 2.50 million, 2.00 million, 45.30 million, and 245.00 million, respectively.
- Therefore, with China getting challenged by the dual pressures of population aging and the steady rise in the prevalence of metabolic risk factors, the burden caused by CVD is likely to increase, which has set new requirements for CVD prevention and treatment and the allocation of medical resources in China.
- The regional companies are focusing on developing advanced products and expanding their product portfolio to cater to the complex requirements of a cardiac procedure. For instance, in January last year, Medtronic plc announced that the National Medical Products Administration (NMPA) had approved the CoreValve Evolut PRO TAVR (Transcatheter aortic valve replacement) system to treat severe aortic stenosis (AS) for symptomatic patients in China who are at high or extreme risk for open-heart surgery.
Understand The Key Trends Shaping This Market
Download PDF
Rising Chronic Diseases is Expected to Drive the Market Growth
- The World Bank projected that over 400 million Chinese people could be over 60 years old by 2050. With the rapid development of the economy, environmental changes, aging, unhealthy lifestyles such as tobacco use, unhealthy nutrition, and physical inactivity constantly spring up. Now, China is facing the formidable challenge of chronic diseases.
- Further, according to the National Center for Biotechnology Information research, focusing on chronic illness and aging in China, there is a progressive shift in the burden of disease to chronic Non-Communicable Diseases (NCDs).
- Almost 80% of deaths in China in people aged 60 years are from chronic NCDs, the most burdensome being Ischemic Heart Disease, Stroke, Chronic Obstructive Pulmonary Disease (COPD), and Type 2 Diabetes. Smoking, alcohol consumption, sedentary behavior, and poor dietary intake contribute significantly to these conditions.
- Additionally, according to the Chinese medical journal, it is estimated that the number of new cancer cases reached 19.3 million globally, and nearly 10 million people died from cancer in 2020. Furthermore, female breast cancer displaced lung cancer and became the most substantially diagnosed cancer for the first time. With the rising, increasing population and chronic diseases in the nation, the demand for minimally invasive surgical equipment is soaring.
Get Analysis on Important Geographic Markets
Download PDF
China Minimally Invasive Surgery Devices Industry Overview
The China Minimally Invasive Surgery Devices Market is a moderately competitive market with significant players like Medtronic Plc, Stryker Corporation, Becton, Dickinson, and Company, HOYA Corporation, etc. The companies in the market are committed to adopting advanced technologies and innovations through partnerships and acquisitions.
- January 2023- Agilis Robotics announced the successful completion of the second round of live animal testing using its proprietary robot, The Agilis Robotics System. This system is a robotic surgical solution designed for endoscopic surgery, featuring a set of flexible surgical robotic instruments, a positioning cart, and a surgeon's control chair.
China Minimally Invasive Surgery Devices Market Leaders
-
Medtronic Plc
-
Zimmer Biomet
-
Smith+Nephew Plc
-
CONMED Corporation
-
HOYA Corporation
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
China Minimally Invasive Surgery Devices Market News
- November 2022- Implanet announced the signing of a distribution agreement for its JAZZ range in China and a technology partnership with Sanyou Medical. The partnership has been done on a commercial and technological level by signing a distribution agreement for the entire JAZZ range in China and jointly developing a new and innovative range of fixation systems for the Western markets. This partnership aims to jointly develop a brand-new European hybrid fixation system range, including the latest developments and innovations in the field of spine surgery, such as minimally invasive range, deformation treatment systems, robotics, artificial intelligence, and many other technologies.
- July 2022- Joimax, a Germany-based company, announces their exclusive partnership for the Chinese market to provide joimax products to surgeons and medical practitioners throughout China solely through Andeller (Nanjing) Healthcare and Technology Co., Ltd. The product Listing will include technologies and training methods for full-endoscopic and minimally invasive spinal surgery.
China Minimally Invasive Surgery Devices Industry Segmentation
Minimally invasive surgery involves surgical techniques requiring fewer incisions or shorter recovery time. A minimally invasive medical device is implanted within a patient during such surgery. Many procedures involve using arthroscopic or laparoscopic devices and remote-control instrument manipulation with indirect observation via an endoscope or large display panel. The surgery is generally carried out through the skin, a small body cavity, or an anatomical opening and can involve a robot-assisted system.
The China Minimally Invasive Surgery Devices Market is Segmented by Type of Product (Surgical Equipment, Monitoring and Visualization Equipment, Robotic Assisted Surgical Systems, electrosurgical systems), By Technology (Laparoscopy, Endoscopy, Robot - Assisted Methods, Arthroscopic Techniques, Ablative Techniques), By Applications (Cardiac Surgery, Gastrointestinal Surgery, Neurosurgery, Gynecologic Surgery, Urological Surgery, Cosmetic and bariatric surgery).
The market sizes and forecasts are provided in terms of value (USD million) for all the above segments.
| By Type of Product | Surgical Equipment |
| Monitoring & Visualization Equipment | |
| Robotic Assisted Surgical Systems | |
| Electrosurgical systems | |
| By Technology | Laparoscopy |
| Endoscopy | |
| Robot - Assisted Methods | |
| Arthroscopic Techniques | |
| Ablative Techniques | |
| By Applications | Cardiac Surgery |
| Gastrointestinal Surgery | |
| Neurosurgery | |
| Gynecologic Surgery | |
| Urological Surgery | |
| Cosmetic and bariatric surgery |
Need A Different Region or Segment?
Customize Now
China Minimally Invasive Surgery Devices Market Research FAQs
How big is the China Minimally Invasive Surgery Devices Market?
The China Minimally Invasive Surgery Devices Market size is expected to reach USD 1.71 billion in 2025 and grow at a CAGR of 9.45% to reach USD 2.68 billion by 2030.
What is the current China Minimally Invasive Surgery Devices Market size?
In 2025, the China Minimally Invasive Surgery Devices Market size is expected to reach USD 1.71 billion.
Who are the key players in China Minimally Invasive Surgery Devices Market?
Medtronic Plc, Zimmer Biomet, Smith+Nephew Plc, CONMED Corporation and HOYA Corporation are the major companies operating in the China Minimally Invasive Surgery Devices Market.
What years does this China Minimally Invasive Surgery Devices Market cover, and what was the market size in 2024?
In 2024, the China Minimally Invasive Surgery Devices Market size was estimated at USD 1.55 billion. The report covers the China Minimally Invasive Surgery Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Minimally Invasive Surgery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Minimally Invasive Surgery Devices in China Industry Report
Statistics for the 2025 China Minimally Invasive Surgery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Minimally Invasive Surgery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
